Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-07-30Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-07-16Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-07-10An Exploratory Study to Assess the Effects of Fanapt® on Social Cognitive Performance
-
CLINICAL_TRIALS study record update · 2015-07-01Phase 1 Trial of 3-2,4 Dimethoxbenzylidene Anabaseine in Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-24A Randomized Clinical Trial to Assess the Effects of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability in Healthy Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-06-24Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
-
CLINICAL_TRIALS study record update · 2015-06-23Randomized Trial of a Smoking Cessation Program for Persons With SMI
-
CLINICAL_TRIALS study record update · 2015-06-23Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2015-06-22Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-18A Randomized, Open-Label Pharmacokinetic Study of LY03004 Compared to Risperdal® Consta® Following a Single Intramuscular Injection at 25 mg or 50 mg in Stable Patients With Schizophrenia and/or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2015-06-18A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-17Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)
-
CLINICAL_TRIALS study record update · 2015-06-15Medication Adherence and Outcomes in Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-11Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-10The Effectiveness of Supplementing Supported Employment With Behavioral Skills Training
-
CLINICAL_TRIALS study record update · 2015-06-08A Randomized, Multi-site, Parallel-group, Rater-blind Study Comparing Response With Aripiprazole Once Monthly and Standard of Care Oral Antipsychotics in Non-adherent Outpatients With Schizophrenia Identified Using the Brief Adherence Rating Scale
-
CLINICAL_TRIALS study record update · 2015-06-04Dietary Supplement N-acetylcysteine (NAC) as a Novel Complementary Medicine to Improve Cognitive Disfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-03A Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-03Cognitive Behavioral Skills Training for Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-02An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-06-02Niacin Skin Flush Response in Patients With Schizophrenia, Their First Degree Relatives, Bipolar Disorder Patients, and Healthy Controls
-
CLINICAL_TRIALS study record update · 2015-06-02Phase III, Multi-center, Randomized, 12-week, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 40-week Double-blind, Parallel-group, Placebo-controlled Treatment Period.
-
CLINICAL_TRIALS study record update · 2015-06-01Functional Rehabilitation for Older Patients With Schizophrenia (FROPS)
-
CLINICAL_TRIALS study record update · 2015-05-28PDE Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-05-27Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial